MEDICAL CANNABIS

Benchmark Botanics Receives Cannabis Sales Licence From Health Canada

Licence allows Benchmark to supply and sell finished cannabis products to provincial governments throughout Canada

CBD

Benchmark Botanics Announces Closing of Non-Brokered Private Placement For $11,300,000

Benchmark Botanics intends to use proceeds from sale for setting up the company’s extraction operations and general working capital

CBD

Benchmark Signs Definitive Investment Cooperation Agreement with China-Based Zhejiang Yatai Pharmaceutical

New company to become involved in cultivation, manufacture, processing, and R&D of medical cannabis high in CBD

CBD

Benchmark Signs A Strategic Cooperation With China-Based Zejiang Yatai Pharmaceutical

Companies to promote and conduct R&D, production, extraction and the commercial application of CBD and derivative products for medical applications

CANNABIS INDUSTRY

Benchmark Botanics Appoints Hon. James Moore To Board of Directors

Benchmark Botanics appoints former Canadian cabinet minister The Honourable James Moore to its Board of Directors